Electromed, Inc. (NYSE:ELMD) Director Sells $278,640.00 in Stock

Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan sold 8,640 shares of the business’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $32.25, for a total value of $278,640.00. Following the sale, the director now directly owns 71,576 shares of the company’s stock, valued at $2,308,326. This represents a 10.77 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Kathleen Skarvan also recently made the following trade(s):

• On Tuesday, February 18th, Kathleen Skarvan sold 38,954 shares of Electromed stock. The shares were sold at an average price of $29.28, for a total value of $1,140,573.12.

Electromed Price Performance

Shares of ELMD traded down $0.19 during mid-day trading on Wednesday, hitting $29.36. 96,902 shares of the company’s stock were exchanged, compared to its average volume of 107,469. Electromed, Inc. has a 52 week low of $13.74 and a 52 week high of $35.56. The company has a 50-day simple moving average of $31.40 and a 200 day simple moving average of $25.15. The company has a market cap of $251.32 million, a PE ratio of 39.15 and a beta of 0.33.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Electromed from a “strong-buy” rating to a “buy” rating in a research report on Wednesday.

Hedge Funds Weigh In On Electromed

Several hedge funds have recently modified their holdings of the stock. Russell Investments Group Ltd. acquired a new position in Electromed during the fourth quarter worth $37,000. IFP Advisors Inc bought a new position in Electromed during the 4th quarter worth $59,000. Quantbot Technologies LP bought a new stake in Electromed in the 4th quarter valued at about $99,000. Bank of America Corp DE grew its position in Electromed by 179.2% during the fourth quarter. Bank of America Corp DE now owns 4,004 shares of the company’s stock worth $118,000 after buying an additional 2,570 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in Electromed in the fourth quarter valued at about $119,000. Institutional investors own 40.82% of the company’s stock.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.